LogicBio Therapeutics, Inc. Common Stock (LOGC)

LOGC was delisted on the 15th of November, 2022.

• Market cap: $68.2M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.

Employees: 62